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Abstract
The early region 3 (E3) of the human adenovirus (HAdV) genome encodes
proteins that regulate the host immune response to viral infection. The E3 region also
exhibits the highest level of genetic diversity among the genomes of the six (A-F)
species of HAdV. This diversity in genetic content is found primarily between the
highly conserved E3-gp19K and RIDα open reading frames (ORFs). It has been
previously shown that HAdV-C encodes the adenovirus death protein (ADP) in this
location. ADP is an 11.6kDa, transmembrane protein that localizes to the nuclear
membrane, and facilitates the efficient release of progeny virions. HAdV-B1 encodes
three ORFs, E3-20.1K, E3-20.5K and E3-10.9K, in the analogous region of the viral
genome. Since ADP and the three novel HAdV-B1 proteins share several structural
characteristics and location in the E3 region, we hypothesized that one or more of
these unique ORFs play a similar role to ADP in facilitating viral progeny egress.
Reverse transcriptase PCR showed that transcripts of the novel ORFs are expressed at
iv

both early and late time points post infection. Through the examination of ectopically
expressed EGFP fusion proteins, we demonstrated that E3-20.1K, E3-20.5K and E310.9K localize to the plasma membrane and intracellular vesicle-like structures.
Localization to intracellular vesicle-like structures was also observed when the novel
HAdV-B1 E3 proteins fused with short, C-terminal, epitope tags were expressed from
the viral genome. We generated a HAdV-3 knock out mutant virus which lacks the
ability to express the E3-20.1K, E3-20.5K, and E3-10.9K proteins to examine whether
the products of these ORFs are required for viral replication or play a role in
facilitating the release of viral progeny from infected polarized or non-polarized lung
epithelial cells. The knock out virus did not show any impaired growth in nonpolarized A549 cells or polarized Calu3 cells when compared to wild type virus. The
knockout HAdV-B1 mutant also did not show any significant changes in the
development of plaques, size of plaques, or dissemination of the virus on cell
monolayers. Even though the novel E3-20.1K, E3-20.5K, and 10.9K proteins of
HAdV-B1 are encoded in the analogous region of E3 and they share several structural
characteristics with ADP, our experimental data show that they do not play a role in
the release of progeny virions from infected cells.
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Chapter 1: Introduction
Species B human adenoviruses (HAdV-B) are common causative agents of acute
lower respiratory infections in children, as well as the causative agents of outbreaks of
febrile respiratory illness in military recruits (Ryan et al, 2002). Despite their medical
importance, little is understood about their unique molecular biology and
pathogenesis. The Early Region 3 (E3) of the HAdV genome contains the highest
level of genetic diversity among the six species (A-F) of HAdVs fond in humans. This
diversity in genetic content is primarily located between the highly conserved E3gp19K and E3-RIDα open reading frames (ORFs) where species-specific arrays of
genes are encoded (Burgert and Blusch, 2000). Determining the functional
implications of the genetic diversity in this region may provide insight into the
molecular basis of the distinct pathobiology of the different species of HAdVs.
Although the E3 region is not essential for viral replication, it does encode nonstructural proteins that play important roles in the regulation of the host response to
infection at early time points post infection. For examples, the RIDα/β complex is
responsible for EGFR, TNFαR, and FasLR down regulation from the plasma
membrane, and glycoprotein 19K plays an important role in retaining MHC class I in
the ER, preventing the activation of cytotoxic T cells (CTLs). Between the highly
conserved E3-19K and RIDα/E3-10.4K open reading frames, the HAdV-C genome
encodes an 11.6kDa protein that has been termed the Adenovirus Death Protein
(ADP). Tollefson and associates demonstrated that, unlike other E3 proteins, ADP is
primarily expressed at late time points post infection from the major late promoter,
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and is required for efficient viral progeny release in human lung epithelial cells
(Tollefson et al., 1992-1996).
Viruses with large DNA genomes, such as adenoviruses, can use multiple
strategies for viral progeny release (Zheng et al, 2008). The mediators of different
release strategies may be encoded in the highly divergent E3 region. HAdV-Bs encode
two to three E3 proteins of unknown function between E3-gp19K and RIDα. HAdVB1 and HAdV-B2 encode proteins of predicted size 20.1kDa and 20.5kDa. The
HAdV-B1 genome also encodes a highly polymorphic ORF designated E3-10.9K
(Frietze et al., 2011). ADP and the three proteins (E3-20.1K, E3-20.5K, and E310.9K) encoded by HAdV-B1 share the characteristics of viroporins. Viroporins are
comprised of roughly 60-120 amino acids, have a hydrophobic transmembrane
domain, a stretch of basic amino acids close to the transmembrane domains, are
frequently modified with N- or O- linked oligosaccharides, and are expressed at late
time points post infection (Gonzales et al., 2003). Some viroporins can oligomerize to
form pores in a membrane increasing its permeability, however, such an effect has not
yet been shown for the proteins encoded in HAdV-B or -C E3 ORFs. We hypothesize
that one or more of the unique ORFs in the E3 region of HAdV-B1, like ADP,
facilitate the release of progeny virions.
With the exception of ADP, little is known about the functions of the products of
species-specific E3 ORFs. Windheim and Burgert (2001) demonstrated the E3-49K
protein encoded by keratoconjuctivitis-causing HAdV-19a, and other HAdV-Ds,
localizes to the trans-Golgi network and early endosomes in human fibroblast cells.
The E3-49K protein has structural features similar to those of the E3-20.1K and E3-
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20.5K, but its function has not been elucidated. Hawkings and Wold have previously
demonstrated that E3-20.5K, like ADP, is expressed at late times post infection
(1995a). E3-20.5K is also heavily glycosylated which is consistent with the structure
of a viroporin (Hawkins and Wold, 1995a).
In order to investigate the roles of HAdV-B1 E3-20.1K, E3-20.5K, and E3-10.9K
in the release of progeny virions from infected cells, we have generated a triple knock
out mutant (knocking out E3-20.1K, E3-20.5K, and E3-10.9K) and a double knock out
mutant (knocking out E3-20.1K and E3-20.5K) HAdV-3 which lack the ability to
produce the E3 proteins of interest. We have utilized these knock out viruses to
examine the roles of the E3 proteins in plaque formation, plaque morphology,
dissemination of the virus throughout an infected cell monolayer, and in a one-step
growth curve in polarized and non-polarized cell monolayers. Despite being encoded
in the analogous region of the viral genome as ADP, and their viroporin-like
characteristics, our knockout mutant viruses lacking the ability to express E3-20.1K,
E3-20.5K, and E3-9K did not show any impaired growth phenotype in cell
monolayers. Our data demonstrate that the E3-20.1K, E3-20.5K, and E3-9K are not
mediators of progeny viral egress.
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Chapter 2: Background
Structure.
Members of the Family Adenoviridae have non-enveloped capsids between 90
and 100nm in diameter. The adenovirus (AdV) genome consists of double stranded
DNA between 26-45kbp in length. A virus-encoded terminal protein is covalently
attached to the 5` end of each strand of the genome. These terminal proteins act as
primers for replication of the viral genome. The capsid is composed primarily of the
hexon, penton base, and fiber proteins. The capsid contains 240 capsomers of hexon.
A trimer of the hexon protein creates each capsomer. The adenovirus' icosahedral
capsid contains 12 pentons, each composed of the penton base and projecting fiber
proteins. The fiber protein is primarily involved in host receptor binding (LonbergHolm et al., 1969) A schematic of the adenovirus capsid can be found in Figure 1.
The capsid also contains proteins involved in disruption of the endosomal membrane
(Polypeptide VI), stabilization of the capsid (Polypeptide IX), and disassociation of
the capsid after entry (Polypeptide IIIa). Core proteins V, VII, and μ are found within
the capsid and are involved in condensing the viral genome (Russell, 2009).
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Figure 1: An overview of the adenovirus virion. The capsid primarily consists of the
hexon protein, with the penton base and fiber proteins located at each of the twelve
vertices. The capsid encloses the linear, double stranded DNA genome (Russell,
2009).

Classification and taxonomy
The family Adenoviridae comprises four genera: Atadenovirus, Aviadenivirus,
Mastadenovirus, and Siadenovirus. Mastadenovirus contains adenoviruses with
mammalian hosts, including humans. Adenovirus genera are also divided into species
and subspecies. Species are designated with a capital letter. Subspecies are designated
with the capital letter of their species as well as a number. Species are classified by
phylogenetic distance, restriction enzyme profiles, percentage of GC content,
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oncogenicity in rodents, organization of the E3 region of the viral genome, and most
importantly the host range of the virus. Species of adenoviruses contain serotypes,
designated by an Arabic number assigned by the order in which they were discovered.
These serotypes are distinguishable using neutralization assays with horse or rabbit
reference anti-sera. Intraserotypic variation can be further characterized by restriction
enzyme analysis (ICTVbd, 2002). Genome types or genomic variants of a given
serotype are designated with a lower case letter. For example HAdV-7d2 is a genomic
variant of serotype 7.

Genome organization and transcription
The size, organization, and coding content of the adenovirus genome vary
among genera and species. For example the E3 region is only found in the genomes of
members of Mastadenovirus and a few members of Siadenovirus (Davidson et al.,
2003). Frog AdV1 contains the smallest known genome of 26.1kbp and fowl AdV-D
contains the largest genome of 45kbp (ICTVdB, 2002).
The AdV genome contains inverted terminal repeats (ITR) at each end (Davison
et al., 2003) and is divided into transcription units. Genes are transcribed off of both
strands of the DNA. A diagram of the HAdV genome and the location of these
transcription units can be found in Figure 2. HAdV genomes contain five early
transcription units, E1A, E1B, E2, E3 and E4, which are transcribed after entry but
before DNA replication. There are three delayed early transcription units: IX, IVa2,
and E2 late. Each of these early transcription units contains its own unique promoter.
Only one late transcription unit has been identified. The late genes located in this
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transcription unit are transcribed off of the Major Late Promoter (MLP). The late
genes encode primarily structural proteins and are transcribed after the initiation of
DNA replication. Some AdV also encode virus-associated RNA genes (VA RNA) that
stimulate viral gene transcription of both early and late genes including genes in E3
and the late protein Hexon (Svensson and Akusjarvi, 1984). An important role of VA
RNA I is the inhibition of PKR. PKR is activated via interferon and viral dsRNA. The
activated PKR inhibits the recycling of pIF-2, which inhibits cellular and viral protein
production. The highly structured VA RNA I binds to and inhibits PKR (Rahman et
al., 1995)

Figure 2: Transcriptional organization of the HAdV genome. The early
transcription units are marked in red. The late transcription unit, preceded by the
tripartite leader sequence, is marked in blue (Akusjarvi. 2008).

In general, the genes located in a given transcription unit serve related functions.
The E1A genes activate transcription and force the cell into S phase. Apoptosis is
inhibited by genes located in E1B transcription unit. The viral DNA polymerase and
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other genes regulating viral DNA replication are found in E2 and E2 late. The E3
region regulates the host immune response to infection. The products of IX activate
transcription and reorganize the host nucleus. MLP activation is controlled by genes
encoded in IVa2. Structural proteins and progeny virion assembly genes are found in
the late transcription unit (Davidson et al., 2003).
Transcription of AdV genes is activated by the large E1A proteins (Berk et al.,
1979; Nevins, 1981). The production of the E1A proteins begins when the genome
reaches the host cell nucleus after entry (Nevins, 1981). The E1A protein interacts
with cellular transcription factors and is responsible for initiating activation of the
early transcription units (Berk, 2005; Liu and Green, 1994). The small E1A protein is
responsible for the activation of E2 transcription (Bagchi et al., 1990; Phelps et al.,
1991).
The MLP is responsible for the transcription of all the genes found in the late
transcription unit. The MLP is active during early stages of infection, but is over 100
times more active after viral DNA replication has begun (Shaw et al., 1980). The late
transcription unit is transcribed as one large transcript of approximately 28kb (Evans
et al., 1977; Nevins at al., 1978). This transcript is spliced into distinct mRNAs
containing a poly A tail and a 5` untranslated region, 201 bases long, called the
tripartite leader (TPL) sequence (Berget et al., 1977; Chow et al., 1977). The TPL is
generated by splicing three short exon sequences (TPL1, TPL2, and TPL3) together
(Berget et al., 1979). The TPL sequence also enhances the translation of the late
mRNAs (Logan and Shenk, 1984). While the majority of products of the late
transcription unit are structural proteins, the adenovirus death protein encoded in the
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E3 region of HAdV-C is a transmembrane, non-structural protein expressed from the
MLP at late time points post infection (Bhat and Wold, 1986).

Replication cycle
The AdV replication cycle is divided into two temporal stages: early and late.
These stages are defined by the onset DNA replication. The early stage of infection
occurs before DNA replication, and includes receptor binding, entry, un-coating,
transport of the viral genome into the host cell's nucleus, and early viral gene
activation and transcription. The late stage of infection occurs after DNA replication
has begun. At this stage of infection, late genes are expressed, structural proteins are
produced, virion assembly takes place, and progeny virion release occurs from the
infected host cell.
The fiber protein, located at each of the twelve vertices of the icosahedral AdV
particle, mediates attachment of the virion to the host cell (Longberg-Holm et al.,
1969). The host cell receptor protein varies among species of HAdVs. Coxsackievirus
B and adenovirus receptor (CAR), which is a component of the tight junction complex
of polarized epithelial cells (Philipson and Petterson, 2004), serves as the primary
receptor for HAdV-A, -C, -E, and -F. Sialic acid moieties can be used as cellular
receptors by HAdV-Ds (Arnberg et al., 2000). HAdV-Bs, the topic of this thesis, can
use a variety of receptors. The complement regulatory protein CD46 is used by most
members of HAdV-B (Martitila et al., 2005). Recently, desmoglein 2 (DSG-2) was
also shown to be an important cellular receptor for HAdV-B (Trinh et al., 2011).
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The penton base associates with αVβ3/ αVβ5 integrins on the host cell membrane
simultaneously with the fiber protein binding its receptor. The virion is then
internalized by clathrin-coated vessicles into the endosomal pathway (Mathias et al.,
1994; Patterson and Russell, 1983). Binding αVβ3/ αVβ5 integrins on the host cell
membranes activates Rho GTPases and PI3 kinases, which in turn alter the cell's
cytoskeleton (Li et al., 1998a, Li et al., 1998b). In the acidic endosome/lysosome,
protein IIIa and protein VI convert the AdV capsid into a subviral particle (Russell,
2009). The subviral particle, now a shell of hexon, core proteins, and the viral genome,
ruptures the membrane of the endosome/lysosome. The virion enters the cytoplasm
and travels to the nuclear pore complex via interaction of hexon with microtubules
(Dales and Chardonnet, 1973; Greber and Way, 2006; Lepold et al., 2000; Mabit et al.,
2002; Suomalaiene et al., 1999). The viral genome and protein VII are released from
the subviral particle and enter the nucleus through the nuclear pore complex (Greber et
al., 1997). Once inside the nucleus, large E1A and small E1A activate the transcription
of early genes located in the E1B, E2, and E3 transcription unit. The products of these
transcription units prepare the cell for DNA replication. The cell is forced into S phase
by products of E1A and E4. E4 encodes viral factors required for viral DNA synthesis,
and products of E1B, VA RNA, and E3 modulate the host response to infection.
The E2 transcription unit produces the pre-terminal protein (pTP), viral DNA
polymerase (AdPol), and DNA binding protein (DBP), which along with cellular
transcription factor NF1, cellular transcription factor OCT-1, and cellular type 1
topoisomerase NFII, allow the replication of AdV genome (de Jong et al., 2003). A
heterodimer of pTP and AdPol is formed and then binds to the viral ITRs, located at
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both ends of AdV genome. DBP then binds the viral genome, allowing AdPol to begin
DNA synthesis through strand displacement. The genome is synthesized off of the
template strand. The displaced strand forms a pan-handle structure through the binding
of the ITRs at either end of the strand. This pan-handle is recognized by the
pTP/AdPol structure which initializes synthesis of the displaced strand (Lechner and
Kelly, 1977; Liu et al., 2003).
During late stages of infection, structural proteins are translated from MLP
transcripts. The structural proteins encapsidate the viral genome. Virion assembly
occurs in the nucleus of the infected cell. The adenovirus death protein (ADP)/E311.6K of HAdV-C is produced at this stage during infection (Tollefson et al., 1996).
ADP localizes to the nuclear membrane and is involved in the efficient release of
progeny virions (Tollefson et al., 1996b).

Species B human adenoviruses
HAdVs have been classified into seven species, A-G (ICTVbd, 2002) (Table 1).
However, only species A-F have been thoroughly characterized and been detected in
humans. HAdV-B serotypes have been further classified into subspecies B1 and
subspecies B2 based on relative DNA homology (Wadell, 1984). HAdV-B1 contains
HAdV-3, -7, -16, -21, and -50. This thesis focuses on HAdV-3. HAdV-3, -7, -16, and 21 are causative agents of acute lower respiratory infections in the pediatric and
military recruit populations. HAdV-3 and -7 are commonly associated with severe and
fatal infections in pediatric populations worldwide (James et al., 2007; Kajon et al.,
2010; Lee et al., 2010; Selvaraju et al., 2011). Symptoms of HAdV-B infection
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include sore throat, coughing, wheezing, runny nose, congestion, vomiting, abdominal
pain, and diarrhea. HAdV -3, -7, and -21 infections can also result in long term
obstructive lung disease such as constrictive bronchiolitis and bronchiectasis up to ten
years after acute infection (Becroft, 1971; Dehghan et al., 2012l; Herbert et al., 1977).
HAdV-50 was isolated from a patient hospitalized due to AIDS and diarrhea (de Jong
et al., 1999). Subspecies B2 includes HAdV-11, -14, -34, -35. HAdV-B2 can cause
respiratory disease, urinary tract infections, and conjunctivitis (Wold and Horwitz,
2007).
Table 1: The seven species of human adenovirus1.
Species

Serotypes

A

12, 18, 31

B

1

3, 7, 16, 21, 50

2

11, 14, 34, 35

C

1, 2, 5, 6

D

8, 9, 10, 13, 15, 17, 19, 20, 23-30, 32, 33, 36-39, 42-49, 51

E

4

F

40, 41

G

52

1

Clustering within species is based on sequence similarity, associated disease type,
oncogenicity in rodents, phylogenetics, and organization of the E3 region. This thesis
focuses on HAdV-3, a HAdV-B1.

Early region 3 transcription unit
The E3 region of HAdVs encodes non-structural proteins that are not essential
for viral replication in cell culture (Ginsberg et al., 1989; Morin et al., 1987). The E3
is the only region of the adenovirus genome that encodes transmembrane proteins
12

(Wold et al., 1995). The size and number of genes present in the E3 region vary
among species A-F of HAdVs. Species A-F each encode the highly conserved ORFs
E3-10.4K/RIDα, E3-14.5K/RIDβ, and E3-14.7K. HAdV species A-E also encode the
highly conserved E3-12.5K and E3-gp19K. Each species also contains an array of
species-specific ORFs. A map of the E3 region can be found in Figure 3. The majority
of this diversity within E3 occurs between the E3-gp19K and E3-10.4K/RIDα ORFs
(Burgert and Blusch, 2000). The species-specific ORFs encoded within the E3 region
share common structural motifs and may have evolved through gene duplication
events. The high levels of genetic variability could also be the result of adaptive
evolution in order to differentially mediate the immune response of various hosts.
These E3 genes have been described as members of the Conserved Region 1
(CR1) family of genes (Lin et al., 2006). In addition to the CR1 prefix, the CR1 genes
have been assigned Greek letters that correspond with their location in the E3 cassette.
E3-20.1K, E3-20.5K, and E3-9K have been termed CR1β, CR1γ, and CR1δ
respectively (E3-16K is termed CR1α). In order to differentiate them clearly from
other CR1 family members, E3-20.1K, E3-20.5K, and E3-9K will not be referred to
by their CR1 designations throughout the remainder of this thesis. The CR1 family of
genes is not found in the E3 region of Siadenovirus (Davison et al., 2003a).
Interestingly, the CR1 family of genes shares common structural characteristics with
the human cytomegalovirus RL11 family of genes (Davison et al., 2003b). With the
exception of E3-12.5K, the functional roles of the conserved E3 proteins have been
established. The roles of most of the species-specific ORFs, however, remain to be
elucidated (Lichtenstein et al., 2004).
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Figure 3: A representation of the early region 3 transcription unit from members
of HAdVs A-F. Most of the genetic variability in this region occurs between the
highly conserved E3-gp19K and RIDα (E3-10.4K) open reading frames (adapted from
Burgert and Blusch, 2000). The E3-10.9K ORF of HAdV-16 is the ortholog of E3-9K
ORF encoded by HAdV-3.

Functional roles of conserved E3 proteins
Adenoviruses are highly species-specific. This has led to the lack of a suitable
animal model for determining the functions of E3 proteins in vivo. The following
observations on the functions of E3 proteins have been made in vitro.

E3-gp19K
The glycoprotein E3-gp19K is a type I membrane protein expressed at early
times post infection. The N-terminal region contains a signaling sequence that is
cleaved during post-translational modification of the protein, and a C-terminal
transmembrane domain. E3-gp19K localizes primarily to the endoplasmic reticulum
(Lichtenstein et al, 2004). Cytotoxic T-Cell mediated killing of viral-infected cells is
14

modulated by E3-gp19K. This is accomplished by blocking transport of MHC class I
to the plasma membrane, and inhibiting the TAP-MHC class I complex formation
(Andersson et al., 1985; Andersson et al., 1987; Burgert and Kvist, 2002, Bennet et al.,
1999). Blocking MHC class I from being expressed on the cell surface reduces the
killing of infected cells by T cells specific for adenovirus. Independent of its ability to
bind MHC class I, E3-gp19K is also able to mimic TAP and bind tapasin, which is
required for full maturation of the MHC class I (Bennet at al., 2001).

RIDα /RIDβ Complex
The RIDα (E310.4K) - RIDβ (E3-14.5K) complex is made up of two, small type
I transmembrane proteins (Krajcsi et al, 1992a; Krajcsi et al, 1992b). Expression of
RIDα by itself results in localization to the Golgi, while expression of RIDβ alone
results in localization to the Golgi and ER. However, when expressed together, the
RID complex localizes to the plasma membrane. (Lichtenstien et al., 2002; Stewart et
al., 1995; Tollefson et al., 1998). The RID complex is responsible for blocking
apoptosis of infected cells. This is accomplished by down regulating pro-apoptotic
receptors TRAILR1, TRAIL2, TNFR, and FAS ligand receptor and by blocking the
activation of NF-κB (Tollefson et al., 2001; Benedict et al., 2001; Freidman and
Horwitz, 2002). The RID complex can also protect the cell from EGF-mediated
inflammation through down regulation of EGFR (Wold et al., 1999). The RID
complex acts by down regulation of these receptors at the plasma membrane, and not
by degrading mRNA or inhibiting the receptors from reaching the plasma membrane
in a manner similar to E3-gp19K (Lichtenstein et al., 2004). RID removes these
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receptors from the plasma membrane and targets them for degradation through the
lysosome (Carlin et al., 1989; Tollefson et al., 1998; Toth et al., 2002). Internalized
TRAILR1, and FAS ligand receptors were co-localized with LAMP-1 and LAMP-2
through confocal microscopy (Tollefson et al., 1997; Benedict 2001).
Pro-apoptotic receptors, Fas ligand receptor, EGFR, and TRAIL receptors, are
internalized through the tyrosine-sorting signal found on the C-terminal domain of
RIDβ (Lichtenstien et al., 2002). The tyrosine-sorting motif, as reviewed by
Kirchhausen (1999), is defined by the consensus sequence YXXφ. Y is the amino acid
tyrosine, X represents any amino acid, and φ is a hydrophobic amino acid with a bulky
side chain. A di-leucine (LL) sorting motif is located in the cytoplasmic domain of
RIDα, and is critical of the internalization of Fas ligand and EGF receptors (Zanardi et
al., 2003; Hilgendorf et al., 2003). The tyrosine sorting and di-leucine sorting signals
have been shown to interact with clathrin adaptor proteins, and target the receptor for
degradation through the endosomal pathway (Ohno et al., 1995; Bonifacino and
Traub, 2003).

E3-14.7K
E3-14.7K is the only known protein encoded by E3 region that is not an integral
membrane protein. Instead, it localizes to the cytosol and nucleus (Gooding et al.,
1990; Li et al., 1998). During viral infection, and when expressed alone, E3-14.7K can
protect the host cell from TNF-mediated cytolysis through release of arachidonic acid
(Gooding et al., 1988; Gooding et al., 1990; Krajcsi et al., 1996). It has been suggested
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that E3-14.7K could also prevent cell death through the interference of Fas ligand
receptor and by binding Caspase-8 (Chen et al., 1998).

Functional roles of species-specific E3 proteins
E3-6.7K
The E3 region of HAdV-C encodes a unique 6.47kDa transmembrane protein.
E3-6.7K is a type III transmembrane protein that localizes to the ER and potentially to
the plasma membrane with the RID complex (Wilson-Rawls et al., 1990; WilsonRawls and Wold, 1993; Benedict et al., 2001). The E3-6.7K protein is encoded
between the E3-12.5K and E3-gp19K ORFs. E3-6.7K plays an important role in RIDmediated internalization of TRAIL receptors (Benedict et al., 2001). E3-6.7K also
inhibits apoptosis induced by TNF, thapsigargin, Fas ligand, and TNF-mediated
release of arachidonic acid. E3-6.7K is proposed to function mainly in the ER and
maintains cytosolic concentrations of Ca2+ (Moise et al., 2002).

Adenovirus death protein (ADP)
HAdV-C encodes an 11.6kDa protein between the highly conserved E3-gp19K
and RIDα ORFs. This protein has been named the adenovirus death protein (ADP).
Unlike other proteins of the E3 transcription unit, ADP is produced at low levels
during early time points post infection. However, after DNA replication has begun,
there is a switch of ADP transcription from the E3 promoter to the MLP. ADP is then
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produced at levels similar to viral capsid proteins during late time points post infection
(Tollefson et al., 1996a). ADP is responsible for the efficient release of progeny
virions. The loss of ADP results in the formation of small plaques and swollen nuclei
in infected cells. This is due to the inability of the virions to be released from the
nucleus, and not deficiency in the replication of the virus (Tollefson et al. 1996b).
ADP's mechanism of action is still under investigation. ADP does not show any
homology to known caspases or any other proteins involved in cell death. It has been
observed that degradation of cellular DNA and RNA occurs in cells infected with
HAdVs encoding intact ADP. This degradation is not seen in cells infected with a
mutant lacking the ability to transcribe ADP (Tollefson et al., 1996). Through yeast
two hybrid screening and GST pull down assays, the C-terminal domain of ADP was
shown to interact with MAD2B (mitotic arrest deficiency 2B). Cell lysis was slown by
over expressing MAD2B in infected cells (Ying and Wold, 2003). MAD2B has been
implicated in the spindle assembly checkpoint and promoting error-prone DNA
replication (Cahill et al., 1999; Murakumo et al., 2000). However, the role of ADP in
affecting these processes has not been established.
ADP is a type III integral membrane protein with a N-terminal lumenal domain
and a C-terminal cytoplasmic domain. ADP also contains a central signal sequence
that is not cleaved during post-translational modification. The ADP backbone is
modified by a palmitic acid, N- and O- linked oligosaccharide (Scaria et al., 1992;
Tollefson et al., 2003). ADP's subcellular localization varies through the progression
of infection. The protein is initially (16-18 hours post infection) located primarily in
the Golgi. At 18hpi, the protein is then seen in the ER. The amount seen in the ER
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increases until 33hpi, where there is switch to ADP being primarily located at the
nuclear membrane (Tollefson et al., 1992).
ADP in HAdV vectors can be beneficial or detrimental depending on the desired
function of the vector. Unlike other E3 proteins, ADP does not modulate the host
response to infection, but it does enhance the cell-to-cell spread of the virus. Oncolytic
viruses can use this feature as an advantage. However, if the vector is designed to
produce long term transgene expression, then the deletion of ADP from the E3 region
would be advantageous.

Gaps in the current knowledge
HAdV-B1s are the causative agents of severe and fatal respiratory disease. Yet
our understanding of the unique molecular pathobiology of this group of adenoviruses
is still limited. This is due to the fact the HAdV-Cs remain the most commonly studied
of all the known HAdVs. While the core mechanisms of viral replication are most
likely conserved among HAdVs, the way the virus interacts with the host cell and the
host's immune system is expected to be highly variable. The majority of proteins
encoded by the E3 region modulate the host response to viral infection. The E3 region
is a valid target for identifying new mechanisms that are responsible for each virus'
unique molecular biology.
Overall egress of nonenveloped viruses also remains poorly understood. The
budding of enveloped viruses has been well characterized for many different families
and genera. However, it has been assumed that most non-enveloped viruses exit from
the infected cell through lysis. The discovery of ADP has shown that viral egress can
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be much more tightly organized and temporally controlled. Viroporins, which are
small, hydrophobic transmembrane proteins encoded by viruses (Carrasco, 1995),
have also been discovered to play a significant role in the release of nonenveloped
viruses like poliovirus (Aldabe et al., 1996). ADP is encoded in the highly variable
region of E3, between E3-gp19K and RIDα. Since each species of HAdV encodes its
own unique array of species-specific proteins in this region, it is reasonable to
investigate the E3 transcription unit for unique mediators of viral egress.
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Chapter 3: Materials and Methods
Cells
A549 cells (ATCC, #CL-185) were grown in Eagle Minimum Essential Medium
(EMEM) supplemented with 8% (v/v) new born calf serum (NBCS). During infection,
A549 cells were maintained in EMEM with 2% NBCS (v/v). Calu3 cells (ATCC HTB55) were grown in RMPI with 10% fetal bovine serum (FBS) and 2% FBS during
infection. HeLa-T-REx cells (Invitrogen, R7 14-07) were grown in EMEM with 10%
FBS. Cell lines were passed twice per week.

Viruses and infection
The prototype strain of HAdV-3, GB, was used. HAdV-3 is a HAdV-B1. The E3
of HAdV-3p contains the three novel ORFs of interest: E3-20.1K, E3-20.5K, and E3- 9K
(an ortholog of the E3-10.9K protein) located between the highly conserved E3-19K and
E3-10.4K ORFs (Kajon et al., 2005. Frietze et al., 2010; Sirena et al. 2005).
Viral stocks were grown in A549 monolayers and harvested after three
freeze/thaw cycles. Titers of infectious virus for stock preparations and all experiments
were determined by standard plaque assay with an agarose medium overlay (as
previously described by Wold et al, 1999). Virus infections were carried out at a
multiplicity of infection (MOI) of 5 or 10 plaque forming units (PFU) per cell. Medium
on the cells was removed before adding the inoculum. The cells were then incubated for 1
hour at 37˚C with 5% CO2 with rocking every 15 minutes. Following the incubation
period, cells were replenished with infection medium.
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Secondary structural predictions
Hydrophobicity plots of the predicted amino acid sequence of E3-20.1K and E320.5K were generated using ProtScale (Gasteiger et al. 2005, http://us.expasy.org/cgibin/protscale.pl). Candidate signal sequences were determined by using SignalP 3.0
(Emanuelsson at al. 2007, http://www.cbs.dtu.dk/services/SignalP/). Potential Nglycosylation (Gupta et al. 2004, http://www.cbs.dtu.dk/services/NetNGlyc/), Oglycosylation (Julenius et al, 2005, http://www.cbs.dtu.dk/services/NetOGlyc/), and
palmitoylation sites (Ren et al, 2008, http://csspalm.biocuckoo.org/online.php) were
determined using web based prediction programs. The membrane topologies of E3-20.1K
and E3-20.5K were predicted using HMMTOP (Tusnady and Simon, 1998,
http://www.enzim.hu/hmmtop/index.html).

EGFP fusion protein constructs
Due to a lack of antibodies for E3-20.1K and E3-20.5K, C-terminal EGFP fusions
of the two proteins were created to permit the study of subcellular localization in an
ectopic expression system. Each ORF was amplified using high fidelity DNA polymerase
(iProof, Bio-Rad, Hercules, CA). Primers for this amplification introduced convenient
restriction sites for cloning into pEGFP-N1 (Clonetech, Mountain View, CA). For ectopic
expression under tetracycline regulation, the EGFP fusion was subcloned into pcDNA
4/TO (Invitrogen, Carlsbad, CA). The vectors that were generated were designated E320.1K-EGFP pcDNA 4/TO and E3-20.5K-EGFP pcDNA.
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Transfection of HeLa T-Rex cells
HeLa T-REx were plated on 100mm coverslips and transfected with 1ug of E320.1K-EGFP pcDNA 4/TO or E3-20.5K-EGFP pcDNA using Effectene Transfection
Reagent (Qiagen, Valencia, CA) 24 hours after plating. Tetracycline (1ug/ml) was added
to the culture medium 24 hours after transfection to induce expression of the EGFP
fusion proteins. Cells were either fixed with 4% paraformaldehyde, or protein lysates
were collected using RIPA buffer (NaCl, Tris, SDS, Triton X-100, Deoxylcholate,
EDTA).
Generation of mutant HAdV-3 viruses
In order to investigate the roles of E3-20.1K, E3-20.5K, and E3-9K in the HAdV3 life cycle, we generated knockout (KO) viruses lacking the ability to produce HAdVB- specific E3 proteins. These viruses were created using the highly efficient
bacteriophage λ red recombination system in E. coli (Poteete, 2001). Using this system,
we generated the recombinant control HAdV-3-FRT, HAdV-3 -FRT Double KO (lacking
the ability to produce E3-20.1K and E3-20.5K), and HAdV-3-FRT Triple KO (lacking
E3-20.1K, E3-20.5K, and E3-9K). The start codon of each ORF was mutated from a
“ATG” to “ATT”. Additionally, a “TGA” stop codon was introduced downstream of the
mutated start codon.
Dr. Silvio Hemmi provided the chorlamphenicol-resistant bacmid pKSB2Ad3wt
(Sirena et al., 2005) which contains the entire genome of HAdV-3p strain GB (GenBank
accession DQ086466). Dr. Samuel Campos, from the University of Arizona, generated
the ampicillin-resistant shuttle vector pSCE3B containing the entire E3 region of HAdV3p GB (Figure 4A). pSCE3B, was generated to facilitate modification of the E3-20.1K,
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E3-20.5K, and E3-9K ORFs within pKSB2Ad3wt. pSCE3B was constructed by PCR
cloning into plasmid pFZF (Campos and Barry. 2004). Briefly, annealed oligos
containing unique AscI and AgeI sites or AvrII, AflII, and Acc65I sites were cloned in
between the SalI and BamHI sites or NheI and NotI sites of pZFZ respectively, to
generate pFZF2. The E3-20.1K, E3-20.5K, and E3-9K ORFs, as well as ~2.0 kb
upstream and downstream sequences were sequentially PCR-cloned into pFZF2 using the
AscI/AgeI, AvrII/AflII, AflII/Acc65I, SalI/AscI, and Acc65I/NotI sites respectively. The
resulting plasmid, pSCE3B, has each of the E3-20.1K, E3-20.5K, and E3-9K ORFs
flanked by unique restriction sites for modification or replacement of the wild type ORFs
with mutant or epitope-tagged versions and places the Flipase recognition target (FRT)flanked zeocin resistance gene in between the E3-20.1K and E3-20.5K ORFs. The
SalI/NotI fragment of pSCE3B can then be recombined into the pKSB2Ad3wt bacmid
and the FRT-flanked ZeoR cassette can be excised to generate E3-20.1K, E3-20.5K, and
E3-9K mutants.

The pSCE3B shuttle vector underwent site directed mutagenesis to introduce
mutations to the start codon of each novel E3 ORF and introduce the “TGA” stop codon
downstream of the mutated start codon. The newly generated pSCE3B shuttle vectors
were then linearized with SalI and NotI. The E3 fragment released from pSCE3B was
electroportated into E. coli harboring pSKB2Ad3wt and pKD46. The temperaturesensitive replicon pKD46 expresses the λ red recombination genes at room temperature
under the arabinose-inducable BAD promoter (Datsenko and Wanner, 2000). The cells
were electroporated in a 0.2cm gap cuvette in a micropulser (BioRad) set at 2500V. Cells
were then rescued with 1mL of SOC + L-arabinose broth and incubated at room
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temperature with gentle rocking overnight. This resulted in the recombination of the
linearized E3 fragment with pSKB2Ad3wt. Positive clones were selected by plating
100μl of the electroporated cells on LB agar containing 34μg/mL chloramphenicol and
50μg/mL zeocin. Recombinan bacmids were purified via alkaline lysis and electroporated
(in the same conditions as above) into an E. coli stain SW105 (Warming et al., 2005).
Flip recombinase genes were activated after rescue with SOC + L-arabinose broth. Cells
were incubated at room temperature overnight with gentle rocking. This resulted in the
collapse of the FRT-Zeocin-FRT cassette into one 34bp FRT site located between E320.1K and E3-20.5K. Successful recombination also leads to the loss of zeocin resistance.
Cells were plated on 34μg/mL LB agar plates and grown overnight at 30˚C. Colonies

Figure 4: Overview of the recombination strategy used to generate mutant HAdV-3.
A) The shuttle vector pSCE3B encoding the entire E3 region of HAdV-3p. B) Starting
with the linearized E3 region from pSCE3B shuttle vector and the pKSB2Ad2wt. λ Red
recombination E. coli, to insert the E3 fragment from pSCE3B into the pSKB2Ad3wt
bacmid, was followed by Flippase, to remove the zeocin resistance gene and leave behind
a 34bp FRT scar site. The final pSKB2Ad3wt bacmid, containing the mutated E3 region,
is then digested with MluI to linearize the viral genome. The genome is then transfected
into A549 cells, and infectious virus is produced.
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were selected and screened for zeocin sensitivity. An overview of the generation of
recombinant bacmids can be found in figure 4B.

Figure 5: Map of the mutated HAdV-3 E3 ORFs. The E3 region of pSCE3B was
mutated and then recombined with pKSB2Ad3wt. The E3 region of each mutant virus
was sequenced. The above map demonstrates the E3 proteins that were knocked out,
fused with a small, C-terminal epitope tag, and the location of the FRT scar site for each
mutants

The newly generated mutated pKSB2Ad3wt bacmids were then digested with
MluI to linearize the HAdV-3-FRT genome. The 1μg of digested DNA was transfected
into A549 cells using Effectene Reagent (Qiagen, Valencia, CA). The transfected cells
were then incubated for 14 days at 37˚C, with additional media added to the cells at 7
days post transfection. Cells were then subjected to three freeze/thaw cycles at -80˚C and
25˚C to harvest virus. Samples were then clarified by centrifugation, and then passaged in
A549 cells until characteristic HAdV-B cytopathic effect (CPE) was observed. Virus
stocks were grown and tittered in A549 cells. The E3 region of each virus was amplified
by PCR and sequenced to confirm the identity of each virus. Four HAdV-3 mutants were
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generated in this manner: HAdV-3-FRT as a recombination control, HAdV-3-FRTDouble KO (knocking out E3-20.1K and E3-20.5K), HAdV-3-FRT-Triple KO (knocking
out E3-20.1K, E3-20.5K, and E3-9K), and HAdV-3-FRT-Tag (with small, C-terminal
epitope tags fused to each of the three novel E3 proteins) as seen in Figure 5.

Immunofluorescence
EGFP fusion constructs
HeLa TRex cells transfected with EGFP fusions were incubated for 10 minutes at
37˚C with 1μg wheat germ agglutinin conjugated with Alexa Fluor 647 (Molecular
Probes, Carlsbad, CA). Coverslips with cells were then washed 3x in PBS before being
fixed with 4% paraformaldehyde (v/v) for 15 minutes. Cells were quenched after fixation
by washing in PBS with 100mM glycine 3 times for 5 minutes each wash. Coverslips
were submerged in dd H2O before mounting on slides with SlowFade Gold with DAPI
(Molecular Probes, Carlsbad, CA).
Images of transfected HeLa T-Rex cells were acquired with a Ziess
epifluorescence Axioscop with Hamanatsu Digital camera controlled by Slide Book
Images Analysis v5.0 (Intelligent Imaging Innovations, Denver, CO). SlideBook
deconvolved the images using a nearest neighbor algorithm.

HAdV-3-FRT-Tag mutant virus infections
A549 cells were seeded onto 18mm glass coverslips in 12 well plates. When cells
were approximately 80-90% confluent, cells were counted and infected with HAdV-3FRT-Tag at an MOI of 10 PFU/cell. After infection, cells were incubated at 37˚C for 1
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hour, with intermediate rocking. Infected cells were then washed three times in 1XPBS
and replenished with A549 infection medium. Cells were then incubated at 37˚C for 24 or
48 hours post infection.
At 24 or 48hpi, cells were washed three times in 1xPBS. Cells were fixed by
adding 100μl of 4% paraformaldehyde/acetone (mixed at 3:1 ratio) for 10 minutes. After
fixation cells were washed 3x in 1xPBS. Cells were blocked with 10% goat serum
(Jackson Immuno Research, West Grove, PA) and PBS with 0.02% Tween20
(Invitrogen, Carlsbad, CA). After blocking, cells were stained with primary antibodies
targeting the unique epitope tags that were engineered onto the C-terminal end of each of
the E3 proteins under investigation: E3-20.1K-Myc, E3-203.5K-V5, and E3-9K-Flag.
Primary antibodies used were: α-Myc-Tag 9B11 (#2276, 1:500 dilution, Cell Signaling,
Danver, MA), α-V5 Tag (ab9113, 1:1000 dilution, AbCam, Cambridge, MA), αDYKDDDDK Tag (Binds to same epitope as Sigma's Anti-Flag M2 Antibody) (#2368,
1:200 dilution, Cell Signaling), and α-Flag M2 (F3165, 1:200 dilution, Sigma-Aldrich, St.
Louis, MO). Cellular markers for the early endosome (EEA1), late endosome/lysosome
(LAMP2), and the Golgi (Giantin) were counterstained in infected cells. Antibodies used
for the cellular markers were: α-EEA1 C45B10 (#3288, 1:200, Cell Signaling), αLAMP2 GL2A7 (ab13524, 1:200 dilution, AbCam), and α-Giantin (ab24586, 1:1000
dilution, AbCam).
All primary antibodies were made up in 1% Goat serum and 1xPBS with Tween
20 and 100μl of appropriate antibody were added to the cells. Cells were incubated at
room temperature for one hour, while rocking. Cells were then washed 3x in 1xPBS with
three minutes in-between each wash. Appropriate secondary antibodies were prepared in
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1% goat serum, Hoechst stain (H3570, 1:400 dilution, Invitrogen, Carlsbad, CA), and
1xPBS with Tween20. Cells were incubated with 100μl of the appropriate secondary
antibody for one hour, in the dark, while rocking. Cells were then washed 3x in 1xPBS
with three minutes in between washes. Coverslips with attached cells were then mounted
on glass coverslips. Cells were imaged on a Zeiss LSM510 META Confocal Microscope
(Carl Zeiss, Inc., Oberkochen, Germany) at the University of New Mexico & Cancer
Center Fluorescence Microscopy Shared Resource, as funded in detail on:
http://hsc.unm.edu/crtc/microscopy/Faciliy.html.

Reverse transcriptase PCR
A549 cells were infected with HAdV-3p at an MOI of 5 PFU/cell. Total RNA
was isolated at early (8 and 10 hours) and late (20 and 24 hours) time points post
infection using RNAqueous kit (Ambion, Austin, TX) following the manufacture’s
protocol. To remove any contaminating DNA, total RNA samples were treated with
TURBO DNA-free kit (Ambion, Austin, TX). Total RNA was tested for the presence of
DNA after DNase treatment with PCR using primers specific for RIG.
After RNA isolation, cDNA was generated from each sample using 1ug of RNA,
random decamer primers, and the RETROscript kit (Ambion, Autin, TX) following
manufacture’s protocol. cDNA was amplified using GoTaq polymerase (Promega,
Madison, WI) using the manufacture’s protocol. Primers to amplify E3-20.1K, E3-20.5K,
E3-10.9K, Hexon (late time point control), and RIG (reverse transcriptase control) are
detailed in Table X. Agarose gel electrophoresis (in Tris-Borate-EDTA buffer) was used
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to analyze the PCR products. Ethidium bromide staining in a Universal HoodII/Gel Doc
XR camera and the Quantity One software (Bio-Rad, Hercules, CA) were used to
visualize the DNA bands.

Table 2: Primers used for detection of cDNA transcripts of E3-20.1K, E3-20.5K, E39K, Hexon, and RIG/S15
Primer Name
E3-20.1K Forward
E3-20.1K Reverse
E3-20.5K Forward
E3-20.5K Reverse
E3-9K Forward
E3-9K Revese
E3-9K Reverse 58C
Hexon Reverse
RIG/S1 Forward
RIG/S15 Reverse
Ad-3-TPL3

Primer Sequence
5' CCATATTACCTTAAGACATAATCACAC 3'
5' GTGCCATTCCCAATGC 3'
5' CCTTGCAGCTGTAACTTATGG 3'
5' AATCCCACTACCACGGC 3'
5' GTTTCAATCAAATACC 3'
5'CTAATCATAGGAGAATAG 3'
5' GGGACGACTAATCATAGGAGAATAG 3'
5' GGTCTGTTAGGCATGGC 3'
5' TTCCGCAAGTTCACCTACC 3'
5' CGGGCCGGCCATGCTTTA 3'
5' CAGTCGCAATCGCAAG

Annealing Temp
58C
58C
58C
58C
40C
40C
58C
58C
58C
58C
58C

Extension Time
30 sec
30 sec
30 sec
30 sec
30 sec
30 sec
30 sec
45 sec
30sec
30 sec

Plaque Accumulation Assay
A549 cells were infected with 50 plaque-forming units of HAdV-3, HAdV-3FRT, HAdV-3-FRT-Double Knockout, and HAdV-3-FRT-Triple Knockout in 60mm
dishes. After a one-hour incubation at 37˚C with intermediate rocking, cells were
overlayed with 2% MEM agarose overlay. Plaque accumulation was recorded over a 15day period.
Statistics
Mean and standard error were calculated and graphed using GraphPad Prism 5.
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Chapter 4: Results

HAdV-3 E3-20.1K, E3-20.5K, and E3-9K triple knock out mutant does not display
impaired growth in an infected cell monolayer
Species A-F of human adenoviruses contain a species-specific array of ORFs
between the highly conserved E3-gp19K and RIDα ORFs. The only protein encoded in
this region with an assigned function is the adenovirus death protein (ADP) encoded by
HAdV-C. ADP is required for efficient release of progeny virions. The ADP-deficient
HAdV-C pm734.1 shows an impaired growth phenotype when compared to the wild type
HAdV-C Rec700 (Ad-5/2/5) virus in a representative experiment (Figure 6A). To
investigate whether one or more of the products of E3-20.1K, E3-20.5K, or E3-9K act in
a similar manner as ADP with regards to viral egress in HAdV-B1, HAdV-3 mutants
were generated using the recombination strategy described above. The start codons of
E3-20.1K, E3-20.5K, and E3-10.9K were mutated from “ATG” to “ATT” and an
additional “TGA” stop codon was introduced downstream of each mutated start codon in
the pSCE3 shuttle vector before they were recombined with pKSB2Ad3wt. Three mutant
HAdV-3 viruses were generated: wild-type virus (HAd3p-WT), the HAdV-3-FRT control
virus that has underwent the recombination pathway, acquiring the Flippase Recognition
Target (FRT) scar site, with no additional mutations, and HAdV-3-Triple KO with E320.1K, E3-20.5K and E3-10.9K knocked out. After infecting monolayers of A549 cells,
extracellular and total virus were collected at 6, 12, 24, 48, 72, 96, and 120 hours postinfection. Infectious titers in plaque forming units (PFUs) per mL of each sample were
determined by standard plaque assay. In contrast to the HAdV-C ADP deletion mutant no
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significant difference in viral titer was seen at any time point between HAdV-3-Triple
KO virus, HAdV-3-WT, and HAdV-3-FRT control viruses (Figure 6B and C). HAdV-3FRT Double KO was not tested in these experiments. HAdV-3-FRT Double KO does
have an intact E3-9K. However, our lab has shown that deleting E3-9K alone does not
impact growth phenotype of HAdV-3 (Frietze et al., 2012). Furthermore, HAdV-3-FRT
Double KO was tested in a similar experiment using polarized epithelial cells (Figure 7),
and growth phenotype was not impacted in the more physiologically relevant system.

Figure 6: Release of progeny virions from non-polarized A549 cells is not mediated
by E3-20.1K, E3-20.5K, or E3-9K. A549 cells were infected with Rec700 or pm734.1.
Total virus (A) and Extracellular virus (B) were collected at 36, 72, and 96 hours post
infection. Rec700 showed significantly higher total and extracellular infectious viral titers
than pm734. A549 cells were infected with HAdV-3-WT, HAdV-3-FRT, or HAdV-3Triple KO at an MOI of 10 PFU/cell. Total virus (C) and extracellular virus (D) were
collected at 6, 12, 24, 48, 72, 96, and 120 hours post-infection. No significant difference
was seen in total or extracellular titers between the HAdV-3-Triple KO and the wild type
viruses. Viral titers were determined by standard plaque assay on A549 cells.
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The altered release of progeny virions from polarized cells has been observed in
other non-enveloped DNA viruses such as polyomaviruses. In polarized epithelial cells
polyomaviruses are released from the apical side of the infected cells (Clayson et al.,
1989). In order to determine if the novel E3 proteins, 20.1K, 20.5K, or 9K, alter the
release of progeny HAdV-B1 virions in polarized cells, lung epithelial Calu3 cells in
trans-well plates were infected with HAdV-3-WT, HAdV-3-FRT, HAdV-3-Triple KO,
HAdV-3-Double KO. Virus was added to the apical side at an MOI of 10 PFU/cell. Cells
were incubated at 37˚C for one hour with intermediate rocking before both apical and
basal compartment were replenished with infection medium. Apical supernatant was
collected at 48, 76, 96, and 120 h pi and assessed for infectious virus load by standard
plaque assay in A549 cells. No significant difference was seen between the control and
knock out mutant viruses (Figure 7). Taken together, these and the data from nonpolarized epithelial A549 cells, indicate that E3-20.1K, E3-20.5K, and E3-9K do not play
a crucial role in the replication cycle or release of progeny virions in infected cell
monolayers.
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Figure 7: Apical release of progeny
virions from polarized epithelial
cells is not mediated by E3-20.1K,
E3-20.5K, or E3-9K. Calu3 cells
were infected with HAdV-3-WT,
HAdV-3-FRT, HAdV-3-Triple KO,
HAdV-3-Double KO at an MOI of 10
PFU/cell. Medium in the apical
compartment was collected at 48, 72,
96, and 120-hour post infection. Virus
titer was determined by standard
plaque assay on A549 cells. The
knockout mutants reached titers
similar to the wild type and control
viruses.

HAdV-3-Triple KO and HAdV-3-Double KO do not show impaired dissemination
through an infected cell monolayer
The ADP-deficient mutant pm734.1 retains progeny virions in the nucleus of
infected cells (Tollefson et al. 1996b). Due to ineffective release of viral particles, this
mutant does not disseminate through an infected cell monolayer as efficiently as the wild
type virus Rec700. In order to investigate the role of E3-20.1K, E3-20.5K, and E3-9K on
dissemination, A549 cells were infected with HAdV-3-FRT, HAdV-3-FRT-Double KO,
HAdV-3-FRT-TKO, Rec700, and pm734.1 at MOIs of 0.001, 0.01, 0.1 and 1.0 PFU/cell.
Unlike the HAdV-C pm734.1 ADP deletion mutant, HAdV-3-Triple KO and HAdV-3Double KO mutants were able to disseminate through the cell monolayer just as
efficiently as the wild type (data not shown) and HAdV-3-FRT viruses (Figure 8).

Figure 8: Dissemination of HAdV-3 is not affected by the loss of E3-20.1K, E320.5K, or E3-9K. A549 cells were infected with HAdV-3-WT (data now shown),
HAdV-3-FRT, HAdV-3-Triple KO, HAdV-3-Double KO, Rec700, and pm734.1 at
MOIs of 1.0, 0.1, 0.01, and 0.001 PfU/cell. Cells were fixed at eight days post infection.
Rec700 was able to disseminate throughout an infected cells monolayer much more
readily than pm734.1. HAdV-3-Triple KO and HAdV-3-Double KO did not show any
impaired dissemination when compared to HAdV-3-WT and HAdV-3-FRT.
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Accumulation of plaques is not inhibited by the loss of E3-20.1K, E3-20.5K, and
E3-9K
The accumulation of plaques in cells infected with pm734.1, an ADP knockout
virus of HAdV-C, is significantly inhibited when compared to cells infected with the
wild type virus Rec700. When knocked out, ADP was the only product of the E3
region that showed any phenotypic difference on the accumulation of plaques
(Tollefson et al., 1996b). In order to examine if the novel E3 proteins located in
HAdV-B1 play a critical role in the accumulation of plaques, A549 cells were infected
with 50 plaque-forming units of HAdV-3-WT, HAdV-3-FRT, HAdV-3-Triple KO, or
HAdV-3-Double KO. An agarose overlay was added to the infected cells after a onehour incubation with the virus. The number of plaques that appeared were counted
over a 15-day period and were reported as a percentage of the total number of plaques
seen on day 15 (Figure 9). No significant difference was observed between the wild
type, recombination control, and the knockout mutants. The novel proteins located in
the E3 region of HAdV-B1 do not play a discernable role in accumulation of plaques
over time.
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Figure 9: Plaque size is not affected by the HAdV-B1 E3 proteins 20.1K, 20.5K,
and 9K. A549 cells in 60mm dishes were infected with 50 PFUs of HAdV-3-WT,
HAdV-3-FRT, HAdV-3-Triple KO, or HAdV-3-Double KO. Cells were then
overlayed with and agarose medium. The number of plaques that appeared were
counted over a 15-day period and reported as a percentage of the total number of
plaques seen on day 15. The number of plaques that accumulated in the cells
infected with the knockout viruses did not vary significantly than cells infected with
the control viruses.

E3-20.1K, E3-20.5K, and E3-9K do not play a critical role in plaque development
during infection
Tollefeson and colleagues (1996b) observed that when ADP was knocked out in
a HAdV-C, the size of plaques generated by that virus were much smaller than plaques
generated by the wild type virus or any other E3 gene knockout virus. A549 cells were
infected with HAdV-3-FRT, HAdV-3-Triple KO, HAdV-3-Double KO, Rec 700,
pm734.1. Images of the plaques that formed were taken on day 7 post infection (Figure
10A). Six well plates were also infected with HAdV-3-WT, HAdV-3-Triple KO,
HAdV-3-Double KO, HAdV-5p (a wild type species C HAdV), Rec 700, or pm734.1.
The cells were fixed and stain to visualize plaques over an entire cell monolayer
(Figure 10B). Rec700 produced large plaques with extensive CPE. In contrast pm734.1
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produced smaller plaques with less CPE and more cells that appeared to still be viable.
The cells infected with HAdV-3-FRT, HAdV-3-Triple KO, or HAdV-3-Double KO all
produced small plaques with no observable difference in size or amount of CPE present.
It is important to note that HAdVs in general have varying plaque size within one
species. Taking together these and the data collected on the accumulation of plaques,
we can confirm that the novel proteins E3-20.1K, E3-20.5K, and E3-9K do not appear
to play a role in the development of plaques during the infection of A549 cells.

Figure 10: Plaque size is not affected by the subspecies B1 E3 proteins 20.1K,
20.5K, and 9K. A549 cells were infected with HAdV-3-FRT, HAdV-3-Triple KO,
HAdV-3-Double KO, Rec 700, pm734.1 and images of plaques were taken at day 7days post infection (A). A549 cells infected with HAdV-3-WT, HAdV-3-Triple KO,
HAdV-3-Double KO, HAdV-5p, Rec 700, or pm734.1 in a 6 well plate were fixed and
stained to visualize plaques (B). Rec700 produced plaques that were larger than those
seen in cells infected with pm734.1. Plaques observed in cells infected with HAdV-3FRT-TKO or HAdV-3-FRT-DKO did not show any significant difference compared to
those infected with HAdV-3-WT.

Functional motifs located within E3-20.1K, E3-20.5K, and E3-9K
Mutant viruses lacking the ability to produce the E3-20.1K, E3-20.5K, and E39K proteins showed no apparent phenotypic difference in a one-step growth curve,
dissemination throughout a cell monolayer, or plaque size and accumulation when
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compared to the wild type virus. Therefore, in order to obtain clues on the function of
these E3 proteins, structural and functional motifs were analyzed. Structural prediction
software was used to analyze the amino acid sequence of each of the three proteins. A
summary of predicted structural motifs can be found in Figure 11. The E3 region is the
only transcription unit of the HAdV genome to contain integral membrane proteins. A
hydrophobic transmembrane domain was identified near the C-terminal end of each of
the three proteins. The short C-terminal domain was also predicted to be located on the
cytosolic side of a membrane. E3-20.1K and E3-20.5K also contain a short
hydrophobic domain located on the N-terminus. This region was identified as a signal
sequence domain that is predicted to be cleaved off during post-translational
modification. A di-leucine sorting motif was located within the short cytosolic domain
of both E3-20.1K and E3-20.5K. In the analogous region of E3-9K, a tyrosine-sorting
motif was identified. Tyrosine and di-leucine sorting motifs play important roles in the
rapid internalization of receptors from the plasma membrane, and targeting them for
degradation through the endosomal pathway (as reviewed by Bonifiacino and Traub,
2003; Pandey, 2008). A di-leucine sorting motif located in the cytosolic domain of
RIDα has been shown to be critical for the internalization of FasL and EGF receptors
(Zanardi et al, 2003). The cytosolic domain of RIDβ also contains a tyrosine sorting
motif that is required for the internalization of Fas and TRAIL receptors (Lictenstein et
al., 2002). E3-20.1K and E3-20.5K also contain several cysteines in their large Nterminal domains. These cysteines could potentially be used to form immuno-globulin
like doaming, as found in E3-49K, or possibly homodimers or heterodimers. Several
serine and tyrosine residues are also located in the N-terminal domains in each of the E3
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proteins. These amino acids could be phosphorylated and affect the function of these
proteins. Interestingly, E3-20.1K also contains a Src homology 3 ligand motif. This
indicates that E3-20.1K could interact with cellular factors and modulate signal
trafficking. It is important to investigate the importance of the these signal sorting
motifs of E3-20.1K, E3-20.5K, and E3-9K in order to elucidate the functional roles of
these proteins.
Figure 11.

Figure 11: Structural prediction of important domains of E3-20.1K, E3-20.5K, and
E3-9K. Structural prediction software was used to identify structural motifs of the novel
B1 E3 proteins. A hydrophobic, transmembrane domain was located in the C-terminal
domain of each of the three proteins. E3-20.1K and E3-20.5K both contain a
hydrophobic, signaling motif on the N-terminal domain. Each of the three proteins
contain a di-leucine (E3-20.1K and E3-20.5K) or a tyrosine (E3-9K) signal-sorting
motif. E3-20.1K also contains a Src homology 3 ligand motif. Serines and tyrosines,
that have the potential to be phosphorylated, and cysteines that could contribute to the
structure of each protein, have also been marked.
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E3-20.1K, E3-20.5K, and E3-9K are expressed at early and late time points post
infection
ADP is produced primarily after viral DNA replication. Prior to viral DNA
replication, ADP is expressed at low levels from the E3 promoter, however, during late
times post infection, ADP is expressed at much higher levels from the major late
promoter (MLP) (Tollefeson et al., 1996a). In order to gain an understanding of when
the novel B1 E3 proteins might be active, the temporal expression of their RNA
transcripts was examined. A549 cells were infected with HAdV-3-WT or HAdV-3FRT-Tag at a MOI of 5 PFUs/cell. RNA was extracted at early time points, prior to
viral DNA replication (8 and 10 h pi) and late time points after viral DNA replication
had begun (20 and 24 h pi). After DNase treatment, the extracted RNA was used in a
reverse transcriptase PCR (RT-PCR) reaction to produce cDNA. Two sets of primers
were used to detect transcripts of the novel B1 E3 proteins. Primers located within each
ORF were designed to detect the transcripts at any time post infection. To detect
transcripts transcribed from the MLP, a forward was designed within the Tri-partite
Leader sequence 3 (TPL3). This sequence is transcribed from the MLP and is spliced
onto the 5' end of late transcripts. The accompanying reverse is located within the 3' end
of each specific ORF under investigation. Transcripts of the major structural protein
Hexon reverse- transcribed in this manner were used as a control for expression at late
time points post infection. The PCR products were then run on an agarose gel. Using
the primer set located entirely within each ORF, it is apparent that transcripts of E320.1K, E3-20.5K, and E3-9K exist at both early and late time points post infection.
There is a switch, however, to expression of these transcripts at late times (20 and 24
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hours) post infection from the MLP (Figure 12). A larger transcript was also detectable
at late times post infection with HAdV-3-WT in the E3-9K lanes. This transcript has
previously been shown to be a fusion of TPL3, E3-20.5K, and E3-9K (Frietze et al.,
2010). However, this transcript was not found in the E3-9K-FLAG lanes of HAdVFRT-Tag . The tagged mutant virus expresses a large fusion transcript of TPL3, E320.1K-MYC, and E3-20.5K-V5 in the lanes depicting late transcripts for E3-20.5K-V5
(sequencing data not shown). In the lanes depicting late transcripts of E3-9K-FLAG,
small degradation products are seen below the full size E3-9K transcript. These
products have been seen previously in HAdV-3-WT infected cells (Frietze et al., 2010).
The differences in the larger, immature transcripts in the lanes of E3-20.5K and E3-9K
indicate that the splicing of late transcripts is altered in the tagged mutant virus. It is not
clear if the fused C-terminal tags or the FRT scar site is responsible for these
differences. However, the full sized mature transcripts are seen for all three proteins in
the tagged virus, indicating that all of the tagged E3 proteins are being produced by the
virus. It is not apparent from this experiment whether the quantity of transcripts
produced at early time points is significantly different to the quantity produced at late
time points post infection.
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Figure 12: Transcripts of E3-20.1K, E3-2.5K, and E3-9K are expressed at all time
points post infection. During late time points, there is a switch to transcription
from the MLP. RNA was extracted from A549 cells infected with HAdV-3-WT or
HAdV-3-FRT-Tag at a MOI of 5 PFUs/cell. (A) Transcripts of the novel B1 E3 proteins
are expressed at all time points post infection using primers internal to each ORF. (B)
The E3 proteins under investigation are expressed at late time post infection (20 and 24
hours) from the MLP as demonstrated by using a primer located in the TPL3 sequence
as well as a primer located in the 3' end of each E3 protein. (C) RIG was used as a
positive control for the reverse transcriptase reaction. Hexon was used as a control for
late time points post infection.

C-Terminal EGFP fusions of E3-20.1K, E3-20.5K, and E3-9K localize to the
plasma membrane and intracellular vesicle-like structures when expressed in
HeLa TRex cells
The examination of the sub-cellular localization of the novel HAdV-B1 E3
proteins could provide important clues to their function. ADP localizes to the nuclear
membrane during late time points post infection (Tollefson et al., 1966). The
RIDα/RIDβ complex localizes to the plasma membrane and the endocytic pathway
(Gooding et al., 1991, Hilgendorf et al., 2003, Shah et al., 2007). The E3-49K protein
encoded by the E3 region of HAdV-D, contains many similar structural motifs of E320.1K, E3-20.5K, and E3-9K, including a large N-terminal domain with a cleavable
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signaling sequence, a transmembrane near the C-terminal end, and a short C-terminal
domain containing both a tyrosine and di-leucine sorting motifs. E3-49K has been
shown to co-localize with trans-Golgi network and early enodosome (Windheim et al.,
2002). Due to the lack of available antibodies for E3-20.1K, E3-20.5K, and E3-9K, Cterminal EGFP fusion proteins were generated and expressed in HeLa-TREx cells under
tetracycline "on" regulation. Constructs with the EGFP fusions were transfected into
HeLA-TREx. Twenty-four hours post transfection, tetracycline (at a concentration of
1μg/mL) was added to the culture medium to induce expression of the EGFP fusions.
Twenty four hours post induction of the EGFP, cells were stained with wheat germ
agglutinin (WGA) as a marker for the plasma membrane, fixed with 4%
paraformaldehyde , and mounted on glass slide with DAPI stain. Unlike ADP, E320.1K, E3-20.5K, and E3-9K were seen at the plasma membrane and intracellular
vesicle like structures at 24 hours post induction (Figure 13). This further supports the
fact that these proteins do not act in a manner similar to ADP.
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Figure 13: C-terminal EGFP fusion proteins localize to the plasma membrane and
intracellular vesicle-like structures when expressed in HeLa TRex cells. E3-20.1K,
E3-20.5K, and E3-9K were individually expressed as C-terminal EGFP fusions in
HeLa-TRex cells under tetracycline "on" regulation. Twenty-four hours post induction,
the three novel sub-species B1 E3 proteins localized to the plasma membrane and
intracellular, vesicle-like structures.

E3-20.1K, E3-20.5K, and E3-9K localize to intracellular, vesicle-like structures
during infection of A549 cells
The C-terminally fused EGFP tag is larger (26.9kDa) than the proteins under
investigation. Also, the predicted tyrosine and di-leucine sorting motifs are located in
the C-terminal domain of each of the E3 proteins. Having EGFP fused to the C-terminal
end could therefore potentially affect the folding and the ability of cellular proteins to
recognize these sequences thus interfering with trafficking of the EGFP fusion protein
within the infected cell. In order to investigate the sub-cellular localization in a more
physiologically relevant system, the HAdV-3-FRT Tag virus (containing short, Cterminally fused epitope tags on E3-20.1K, E3-20.5K, and E3-9K) (Figure 14A) was
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used to visualize the sub-cellular localization of each novel E3 protein. A549 cells were
mock infected or infected with HAdV-3-FRT (a recombination control) or HAdV-3FRT Tag. Twenty-four hours post infection, cells were fixed with 4% paraformaldehyde/acetone (at a 3:1 ratio). Cells were stained with appropriate anti-tag
antibodies to visualize each individual protein. E3-20.1K, E3-20.5K, and E3-9K all
localized to intracellular, vesicle-like structures (Figure 14B). The pattern of staining
for the E3 proteins was remarkably similar. RIDα and RIDβ, expressed from the E3
region, have been shown to co-localize together at the plasma membrane and the
endocytic pathway (Gooding et al., 1991, Hilgendorf et al., 2003, Shah et al., 2007). In
order to determine if E3-20.1K, E3-20.5K, or E3-9K co-localize with each other, cells
infected with HAdV-3-Tag were stained to visualize two of the B1 E3 proteins at a
time. All possible combinations of E3-20.1K, E3-20.5K, or E3-9K were used. The
novel sub-species B1 E3 proteins did no co-localize with each other during infection of
A549 cells.
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A)

B)

Figure 14: E3-20.1K, E3-20.5K, and E3-9K localize to intracellular, vesicle like
structures, but do not co-localize with each other. A549 cells were infected HAdV-3FRT, HAdV-FRT Tag, or mock-infected. At 24 hours post infection, cells were fixed
and stained with appropriate antibodies to visualize the novel E3 proteins. (A) Map of
the mutant E3 region of HAdV-3-Tag showing the location and type of small epitope
tags fused to the C-terminal domains of E3-20.1K, E3-20.5K, and E3-9K. (B) E320.1K, E3-20.5K, and E3-9K all localize to intracellular, vesicle like structures.
However, they do not co-localize to each other during infection of A549 cells.
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E3-20.1K, E3-20.5K, and E3-9K do not localize with the early or late endosome or
Golgi markers
The presence of di-leucine sorting motif located in E3-20.1K and E3-20.5K and
the tyrosine-sorting motif located in E3-9K is typically associated with targeting a
protein at the plasma membrane for internalization through the endocytic pathway
(Bonifacino and Traub, 2003; Pandey, 2008). In order to investigate whether E3-20.1K,
E3-20.5K, and E3-9K interact with the endocytic pathway, A549 cells were infected
with HAdV-3-FRT, HAdV-3-Tag, or mock-infected. At twenty-four hours post
infection the cells were fixed with 4% para-formaldehyde/acetone (at a 3:1 ratio) and
stained with antibodies against the small, C-terminal, epitope tags. The tagged E3
proteins were counterstained with antibodies against EEA1 (a marker of the early
endosome), LAMP2 (a marker of the late endosome), and Giantin (a marker of the
Golgi). Despite the fact that these proteins all contain a signal-sorting motif, and have
been localized to vesicle like structures in an infected cell, E3-20.1K, E3-20.5K, and
E3-9K did no co-localize with EEA1 or LAMP2. They also did not show any colocalization with the Golgi. However, E3-20.5K and E3-9K have been shown to be
glycosylated and therefore must traffic through the Golgi (Hawkins et al., 1995, Frietze
et al., 2010) (Figure 15). They exact nature and function of these vesicle-like structures
remains to be determined.
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Figure 15: E3-20.1K, E3-20.5K, and E3-9K do not localize to the early endosome,
late endosome, or Golgi. A549 cells were infected with HAdV-3-FRT, HAdV-3-Tag,
or mock-infected. Twenty four hours post infection, cells were fixed and stained with
antibodies against the small epitope tags fused to each novel E3 protein, EEA1 (a
marker for the early endosome), LAMP2 (a marker of the late endosome, and Giantin (a
maker for the Golgi).
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Chapter 5: Discussion
The Early Region 3 contains the highest level of genetic diversity among the
HAdV. The known functions of the majority of the proteins encoded in the E3 region
implicate them in the modulation the host response to infection (as reviewed by Bugert
and Blusch, 2000; Lichtenstein et al., 2004). The adenovirus death protein (ADP) is one
known exception. ADP is a transmembrane protein that localizes to the nuclear
membrane and is required for the efficient release of HAdV-C virions from infected
cells at late time points post infection (Tollefson et al., 1992; Tollefson et al., 1996;
Doronin 2003). ADP is encoded between the highly conserved E3-gp19K and RIDα. In
this particular region of the genome, species A-F of HAdVs encodes a species-specific
array of one to three predicted proteins (Burgert and Blusch, 2000). With the exception
of ADP, no function has been assigned to any of these species-specific E3 proteins. In
the analogous region of the genome, HAdV-B1s encode three novel transmembrane
proteins designated E3-20.1K, E3-20.5K, and E3-10.9K by their predicted molecular
weight. Due to their location in the E3 region, and the presence of a transmembrane
domain, we hypothesized that one or more of these proteins act in a similar manner as
ADP and are required for efficient release of progeny virions from infected cells.
In order to test our hypothesis, we generated a mutant HAdV-3 lacking the
ability to produce E3-20.1K, E3-20.5K, and E3-9K. This mutant virus was used to
examine growth phenotype characteristics in A549 cells compared to a wild type
HAdV-3 as well as adequate recombination controls. There was no significant
difference observed between the wild type and knockout mutants. These data allowed
us to conclude that our original hypothesis was incorrect.
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The amino acid sequence of the three HAdV- B1 E3 proteins was analyzed to
gain additional insight into their potential functions. A transmembrane domain was
found in E3-20.1K, E3-20.5K, and E3-9K polypeptides. Potential signal sorting motifs
are present in their short, C-terminal cytosolic domains. Despite the presence of these
sorting signals, we were not able to co-localize these E3 proteins to compartments of
the endocytic pathway. However, the proteins under investigation were localized to
intracellular, vesicle-like structures and potentially the plasma membrane.
Many of the proteins encoded by the E3 region are involved in modulating the
host cell response to infection. E3-gp19K binds and retains MHC class I in the
endoplasmic reticulum, the RID complex targets receptors at the plasma membrane and
targets them for degradation, and E3-14.7K can protect the infected cell from proapoptotic factors (as reviewed by Lichtenstein et al., 2004). Although neither E3-20.1K,
E3-20.5K nor E3-9K co-localized with markers of the endocytic pathway, as seen with
HAdV-D E3-49K (Windheim and Burgert, 2002), it is still likely that these novel E3
proteins interact with and modify some cellular response to viral infection.

E3-20.1K, E3-20.5K, and E3-9K do not mediate the release of progeny virions
In order to elucidate the roles of the novel E3 proteins in the life cycle of HAdVB1s, we generated a HAdV-3 knock out. Our initial hypothesis was that one or more of
these proteins were involved in progeny virion egress. An ADP deletion mutant of
HAdV-C showed a significant drop in both extracellular and intracellular infectious
virus titers when compared to the corresponding wild type HAdV-C in A549 cells. In
order to investigate whether E3-20.1K, E3-20.5K, or E3-9K function in a similar
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manner, a one step growth curve was carried out with wild type virus and our HAdV-3
triple knock out mutant. No significant difference was observed between the wild type
and the triple knockout mutant in non-polarized A549 cells. Although A549 cells are a
standard cell line for the study of HAdV infection, they do not simulate polarized cells
that these viruses would encounter in a more physiologically relevant system. Other
viruses with a DNA genome such as polyomaviruses have shown differential release in
a polarized cell system (Clayson et al., 1989). In order to simulate a more
physiologically relevant system, this experiment was replicated in a polarized lung
epithelial cell line, Calu3. Again, no difference was seen between the wild type and
knock out mutant viruses. Since no significant drop in viral titer was observed in
infected cells compared to wild type virus, we concluded that the E3-20.K, E3-20.5K,
and E3-9K proteins do not mediate viral progeny release in a manner similar to ADP.
Although these novel E3 proteins do not play an important role in the release of
progeny virions, it is still possible that they are implicated in another important stage in
the viral life cycle.

E3-20.1K, E3-20.5K, and E3-9K knockout mutants do not alter dissemination of the
virus, plaque size or morphology, or plaque accumulation
In order to further characterize the roles of E3-20.1K, E3-20.5K, and E3-9K on
the viral replication cycle, we used HAdV-3 knock out mutants for these genes to look
at any differences in plaque accumulation and morphology as well as the virus' ability to
disseminate throughout an infected cell monolayer when compared to the wild type
virus. An ADP deletion mutant show a decreased ability to disseminate throughout an
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infected cells monolayer (Doronin et al., 2003). To investigate whether E3-20.1K, E320.5K, and E3-9K knock out mutants had a similar phenotype, a dissemination assay
was carried out on A549 cells. Cells were infected with ten-fold serial dilutions. In
contrast to the ADP knock out mutant and the wild type HAdV-C viruses, no
phenotypic difference was seen between the mutant and wild type species B1 viruses.
The ADP knock out mutant has also been shown to produce plaques of smaller
size when compared to the parental virus. No other mutant HAdV-C has produced a
similar effect when any other E3 proteins were individually knocked out. Plaques of the
ADP knockout mutant also displayed reduced cytopathic effect (Tollefson et al., 1996).
We infected A549 cells with either HAdV-3 wild type or knockout mutants and
examined their plaque size and morphology during the course of infection. The plaques
of both the wild type and mutants were similar in size. It should be noted, however, that
the plaques of HAdV-3 are much smaller than the plaques of a HAdV-C. The plaques of
both the mutant and the wild type viruses showed similar magnitude of CPE. Overall,
the lack of E3-20.1K, E3-20.5K, and E3-9K did not produce any observable effect on
the plaque size or morphology in infected cell monolayers.
In addition to exhibiting a reduced plaque size, the HAdV-C ADP knockout
virus accumulated plaques at significantly reduced rate when compared to the wild type
(Tollefson et al., 1996). Monolayers of A549 cells were infected with 50 total plaqueforming units of our wild type and knockout HAdV-3 mutants in order to determine if
E3-20.1K, E3-20.5K, and E3-9K play a role in the formation and accumulation of
plaques. The number of plaques that formed were counted over a course of two weeks.
The HAdV-3-Double or Triple knockout viruses produced plaques at the same rate as
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the wild type viruses. One step growth curves as well as the plaque morphology in cell
monolayers infected with E3-20.1K, E3-20.5K, and E3-9K knock out mutants have
revealed that these three novel E3 proteins do not mediate or contribute to the release of
progeny virions in a manner similar to ADP.

Structural and functional motifs of E3-20.1K, E3-20.5K, and E3-9K
Since the original hypothesis of E3-20.1K, E3-20.5K, or E3-9K having a similar
function as ADP was proven to be incorrect, we decided to investigate other possible
functions for the novel E3 proteins. Structural prediction software can identify
important structural domains and functional motifs by analyzing the amino acid
sequence of the proteins under investigation. Using structural prediction software, we
observed that E3-20.1K, E3-20.5K, and E3-9K enocode a hydrophobic transmembrane
domain towards their C-termini. E3-20.1K and E-20.5K have very similar structures. In
addition to the transmembrane domain, each of these proteins contains a hydrophobic
signal sorting sequence on the N-terminal domain. The N-terminal domain for all three
proteins is predicted to by luminal, while the short C-terminal domain is predicted to be
cytosolic. The three E3 under investigation encode serine and tyrosine residues that
could potentially be phosphorylated. E3-20.1K also contains a Src homology 3 ligand
motif, suggesting that it could interact with cellular factors influencing trafficking. The
fact that these proteins share such similar predicted structures, along with other
members of the CR1 family of genes, supports the notion that these genes may have
evolved through gene duplication events (Davison et al., 2003).
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In addition to the hydrophobic domains, each protein is predicted to have a
signal-sorting motif in their short cytosolic domain. E3-20.1K and E3-20.5K both
encode a di-leucine sorting motif, while E3-9K encodes a tyrosine-sorting motif. These
sorting motifs are used for the rapid internalization of receptors from the plasma
membrane, and their targeting towards the endocytic pathway (reviewed by Pandely,
2008). These sorting motifs could be important clues towards the function of the E3
proteins under investigation. It is important to investigate whether E3-20.1K, E3-20.5K,
and E3-9K localize to the plasma membrane, or interact with components of the
endocytic pathway.

Subcellular localization of E3-20.1K, E3-20.5K, and E3-9K
The subcellular location of E3-20.1K, E3-20.5K, and E3-9K may provide
important clues to the functional roles of the novel E3 proteins. Due to the lack of
available antibodies against the E3 proteins under investigation and for an initial
examination of subcellular localization, we decided to express E3-20.1K, E3-20.5K,
and E3-9K individually as C-terminal EGFP fusion proteins in HeLa-TREx cells. E320.1K, E3-20.5K, and E3-9K were cloned into a mammalian expression vector with
tetracycline "on" regulation. The EGFP fusion constructs were individually transfected
into HeLa-TREx cells. Twenty-four hours post induction of expression, cells were
fixed, counterstained with DAPI and wheat germ agglutinin (as a plasma membrane
marker). The C-terminal fused EGFP fusion proteins were localized at the plasma
membrane as well as intracellular vesicle like structures. Several other HAdV E3
proteins have similar subcellular localization. The RIDα/β complex acts to internalize
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several plasma membrane receptors, such as EGFR, FasL-R, and TRAIL-R from the
plasma membrane and target them for degradation through the endocytic pathway
(Gooding et al., 1991, Hilgendorf et al., 2003, Shah et al., 2007). However, the EGFP
protein alone is very large (26kDa). It is also fused to the C-terminal domain were the
tyrosine and di-leucine sorting motifs are located. The fused EGFP protein may be
interfering with proper transportation or sorting of these novel E3 proteins. The EGFP
fusions were also expressed independently of any other viral proteins. If one or more of
these E3 proteins function together, we may not be seeing the correct co-localization or
trafficking of these proteins.
In order to examine the expression of these proteins in a more physiologically
relevant system, a mutant HAdV-3 was generated with small, unique epitope tags fused
to the C-terminal domain of each E3-20.1K, E3-20.5K, and E3-9K. Our tagged mutant
was used to infect A549 cells. Twenty-four hours post infection, cells were fixed and
stained with antibodies against the individual epitope tags. E3-20.1K, E3-20.5K, and
E3-9K localized to vesicle like structures within the cytoplasm of infected cells. These
findings matched the intracellular structures that were seen with the EGFP fusion
proteins. However, no strong localization was seen at the plasma membrane. This
suggests that the large EGFP tag was in fact interfering with the correct localization or
sorting of the novel E3 proteins. RIDα and RIDβ co-localize with each other and are
dependent on each other to be completely functional (Gooding et al., 1991). Since E320.1K, E3-20.5K, and E3-9K each had very similar subcellular localization, we
examined whether or not these E3 proteins co-localized with each other. When we
stained cells infected with the HAdV-3 tagged mutant, and stained for two of the
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proteins under investigation at a time, it was observed that none of the HAdV-B1 E3
proteins co-localized with each other.
In their short C-terminal domains, E3-20.1K, E3-20.5K, and E3-9K encode
signal-sorting sequences that are known to interact with the early and late endosomes.
Because the novel E3 EGFP fusion proteins were visualized as unidentified intracellular
vesicle-like structures, it is important to investigate their interaction with the early and
late endosomes. The early endosome and late endosome are important components of
the endocytic pathway, and EEA1 (early endosome) and LAMP2 (late endosome) were
chosen as markers of the endocytic pathway. A549 cells were infected with the tagged
mutant, and stained individually for E3-20.1K, E3-20.5K, or E3-9K, and either EEA1 or
LAMP2 twenty hours post infection. Despite the encoding di-leucine or tyrosine sorting
motifs in the C-terminal domains of E3-20.1K, E3-20.5K, and E3-9K, they did not colocalize with EEA1 or LAMP2. The cellular and/or viral interactors of E3-20.1K, E320.5K, and E3-9K remain unknown. Clathrin-mediated endocytosis is another important
pathway of internalization from the plasma membrane. Colocalization of E3-20.1K,
E3-20.5K and E3-9K with components of clathrin coated pits should be investigated in
future studies.

Future directions
In order to identify potential cellular interactors of E3-20.1K, E3-20.5K, and E39K, these proteins could be cloned for screening using a yeast two hybrid system
(Y2H). Since the hydrophobic and unorganized transmembrane domains can generate
false positives in the Y2H system, the E3 proteins as a whole cannot be cloned into the
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Y2H bait vectors. In order to find potential interactors then, the larger N-terminal
domain, excluding the hydrophobic signal sequences of E3-20.1K and E3-20.5K, and
the shorter C-terminal domains could be cloned independently into the Y2H bait vector.
The larger N-terminal domain would probably identify any cellular interacting proteins.
The shorter C-terminal domains could potentially detect any cellular proteins within
infected cells that act in the sorting and trafficking of the E3 proteins in an infected cell.
The results of the Y2H experiment could be confirmed using the HAdV-3-FRTTag mutant virus. E3-20.1K, E3-20.5K, and E3-9K could be individually pulled down
through an immuno-precipitation targeting the small epitope tag fused to each E3
protein under investigation. The targets identified in the Y2H experiment could then be
probed by western blot to determine if they do in fact interact with E3-20.1K, E320.5K, or E3-9K. This approach could also be used to determine any potential
interactors not identified by Y2H. After the immuno-precipitation targeting the small
epitope tags fused to E3-20.1K, E3-20.5K, and E3-9K, the proteins pulled down
through IP could then be run on a 2D gel to identify any other interactors. Any
interactors could be further identified by mass spectrometry.
If E3-20.1K, E3-20.5K, and E3-9K interact with an unknown receptor at the
plasma membrane and internalize that receptor in a manner similar to the RID complex,
isolating the plasma membranes from infected cells could prove to be useful.
Membranes infected with wild type, knockout, and mock-infected cells could be probed
for common receptors involved in regulating the host cell's response to infection such as
EGFR, TRAIL, or FasL receptors. If E3-20.1K, E3-20.5K, and E3-9K interacts with a
receptor at the plasma membrane and internalizes it, we would see reduced levels of the
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receptor in membranes infected with the wild type HAdV-3. The cells infected with a
knock out mutant, however, would still retain that receptor at the plasma membrane at
normal levels.
E3-20.1K, E3-20.5K, and E3-9K could have profound effects on the ability of
virus to modify the host's immune response to HAdV infection that could be impossible
to observe in cell cultures. An infection in an animal model would be ideal to determine
if the novel E3 proteins are crucial for the proper replication of HAdV-B1s or control of
the host's immune response to infection. Unfortunately, because HAdVs are highly
species-specific, there are no suitable animal models for HAdV infection. While early
events of viral infection can be initiated, no animal model can produce progeny virions
(Toth et al., 2005; Lam et al., 2011). Therefore the roles of these proteins in the late
stages of viral infection cannot be investigated.
Species A-F of HAdVs have evolved species-specific arrays of open reading
frames in the E3 region of their genome. While the function for HAdV-C E311.6K/ADP has been established, the functional role of the products of the rest of these
ORFs remains unknown. Although E3-20.1K, E3-20.5K, and E3-9K do not function in
a similar manner as ADP, their potential as role in modulators of the host cell's response
to viral infection remains to be determined. The continued investigation into the
functional roles of these proteins is important to further understand the various ways
viruses interact with their host cells and subvert anti-viral responses.

58

Appendix: Acronyms
ADP

Adenovirus death protein

AdV

Adenovirus

CAR

Coxsackievirus and adenovirus receptor

CPE

Cytopathc effect

DBP

DNA binding protein

E3

Early Region 3

EGFP

Enhanced green fluorescent protein

EGFR

Epidermal growth factor receptor

EMEM

Eagle Minimum Essenial Medium

FasLR

Fas ligand receptor

gp

Glycoprotein

HAdV

Human adenovirus

ICTV

International Committee of Taxonomy of Viruses

MLP

Major Late Promoter

MOI

Multiplicity of infection

ORF

Open reading frame

PFU

Plaque forming units

RID

Receptor internalization and degradation

TNFα

Tumor necrosis factor

TPL

Tripartite leader

VA RNA Virus associated RNA
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